| 9.5 |
28.4 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 6.9 |
27.6 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 6.9 |
20.6 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 5.9 |
35.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 4.9 |
4.9 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 4.8 |
14.5 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 4.5 |
18.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 4.4 |
17.8 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 4.4 |
31.0 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 4.2 |
8.5 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 4.2 |
16.8 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 4.0 |
16.2 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 3.9 |
23.7 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 3.8 |
19.1 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 3.7 |
3.7 |
GO:0043366 |
beta selection(GO:0043366) |
| 3.7 |
11.1 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 3.6 |
14.4 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 3.6 |
28.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 3.5 |
21.2 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 3.3 |
13.3 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 3.3 |
10.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 3.3 |
3.3 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 3.3 |
26.3 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 3.3 |
9.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 3.2 |
9.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 3.2 |
3.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 3.2 |
12.8 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 3.2 |
9.6 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 3.2 |
9.6 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 3.2 |
19.1 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 3.1 |
18.8 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 3.1 |
9.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 3.0 |
15.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 3.0 |
9.0 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 2.9 |
5.8 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 2.9 |
8.6 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.8 |
19.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.8 |
11.2 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 2.8 |
8.3 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 2.7 |
11.0 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 2.7 |
8.2 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 2.7 |
2.7 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 2.7 |
2.7 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 2.7 |
5.4 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 2.7 |
13.3 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 2.7 |
16.0 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 2.6 |
7.9 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 2.6 |
7.9 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 2.6 |
31.0 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 2.6 |
10.3 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 2.6 |
51.0 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 2.5 |
10.1 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 2.5 |
7.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 2.5 |
5.0 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 2.5 |
22.4 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 2.5 |
12.4 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 2.5 |
12.4 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 2.4 |
7.3 |
GO:0046544 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) |
| 2.4 |
12.1 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 2.4 |
16.9 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 2.4 |
21.5 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 2.4 |
7.2 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 2.4 |
16.7 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 2.4 |
9.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 2.3 |
56.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 2.3 |
7.0 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 2.3 |
18.5 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 2.3 |
2.3 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.3 |
9.0 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 2.2 |
6.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.2 |
11.2 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 2.2 |
6.7 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.2 |
6.7 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 2.2 |
15.5 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 2.2 |
6.5 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 2.2 |
2.2 |
GO:0072095 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 2.2 |
10.8 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 2.1 |
2.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 2.1 |
63.0 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 2.1 |
6.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 2.1 |
12.4 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 2.1 |
6.2 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 2.1 |
10.3 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 2.0 |
8.0 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 2.0 |
6.0 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.0 |
4.0 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 2.0 |
7.9 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 2.0 |
11.9 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 2.0 |
9.8 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 2.0 |
11.8 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 1.9 |
13.5 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 1.9 |
5.8 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 1.9 |
11.5 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 1.9 |
7.7 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.9 |
7.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.9 |
1.9 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 1.9 |
7.6 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.9 |
5.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.9 |
9.4 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 1.9 |
3.8 |
GO:0000237 |
leptotene(GO:0000237) |
| 1.9 |
20.6 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 1.9 |
3.7 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 1.9 |
7.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.9 |
27.9 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 1.8 |
5.5 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 1.8 |
5.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 1.8 |
3.7 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 1.8 |
1.8 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 1.8 |
5.5 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 1.8 |
14.4 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 1.8 |
25.1 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 1.8 |
5.4 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 1.8 |
9.0 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 1.8 |
10.7 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 1.8 |
9.0 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.8 |
8.8 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 1.8 |
8.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.8 |
5.3 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 1.7 |
7.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.7 |
3.5 |
GO:0006312 |
mitotic recombination(GO:0006312) |
| 1.7 |
8.7 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 1.7 |
64.2 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 1.7 |
3.4 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 1.7 |
5.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.7 |
1.7 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 1.7 |
5.1 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.7 |
5.0 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 1.6 |
4.9 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.6 |
3.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 1.6 |
4.9 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 1.6 |
4.9 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 1.6 |
8.1 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 1.6 |
8.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 1.6 |
4.8 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 1.6 |
11.3 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.6 |
6.4 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 1.6 |
4.8 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 1.6 |
4.8 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 1.6 |
4.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.6 |
6.3 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 1.6 |
7.9 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 1.6 |
42.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 1.6 |
9.4 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.6 |
3.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 1.6 |
56.2 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 1.5 |
13.9 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.5 |
4.6 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 1.5 |
10.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.5 |
6.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 1.5 |
7.6 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 1.5 |
3.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.5 |
3.0 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.5 |
6.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.5 |
3.0 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.5 |
13.4 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 1.5 |
5.9 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 1.5 |
4.4 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 1.5 |
1.5 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 1.5 |
7.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.5 |
11.7 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.5 |
1.5 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 1.5 |
14.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 1.4 |
4.3 |
GO:0045472 |
response to ether(GO:0045472) |
| 1.4 |
2.9 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.4 |
14.4 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 1.4 |
4.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 1.4 |
2.8 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) nephric duct formation(GO:0072179) |
| 1.4 |
1.4 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.4 |
2.8 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 1.4 |
47.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 1.4 |
6.9 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 1.4 |
6.8 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 1.3 |
8.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 1.3 |
4.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 1.3 |
4.0 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.3 |
17.4 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.3 |
2.7 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.3 |
11.9 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 1.3 |
1.3 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.3 |
32.8 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 1.3 |
23.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 1.3 |
2.6 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 1.3 |
7.9 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 1.3 |
3.9 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 1.3 |
3.9 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.3 |
24.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 1.3 |
9.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.3 |
2.6 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 1.3 |
10.3 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 1.3 |
33.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 1.3 |
5.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 1.3 |
3.8 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 1.3 |
2.5 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 1.3 |
2.5 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.3 |
3.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 1.3 |
3.8 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 1.2 |
2.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.2 |
21.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 1.2 |
13.6 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 1.2 |
12.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 1.2 |
1.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 1.2 |
2.5 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.2 |
3.7 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 1.2 |
2.4 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 1.2 |
10.9 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.2 |
2.4 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 1.2 |
12.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 1.2 |
3.6 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.2 |
1.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 1.2 |
3.6 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 1.2 |
5.8 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 1.2 |
3.5 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.2 |
2.3 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 1.2 |
20.9 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 1.2 |
3.5 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 1.2 |
10.4 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 1.1 |
2.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 1.1 |
4.5 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.1 |
9.0 |
GO:0009650 |
UV protection(GO:0009650) |
| 1.1 |
1.1 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 1.1 |
2.2 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 1.1 |
4.5 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.1 |
1.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 1.1 |
3.3 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 1.1 |
2.2 |
GO:1904705 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
| 1.1 |
3.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.1 |
3.3 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 1.1 |
5.5 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 1.1 |
19.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 1.1 |
3.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 1.1 |
1.1 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 1.1 |
3.3 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 1.1 |
12.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 1.1 |
2.2 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 1.1 |
4.3 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.1 |
3.2 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 1.1 |
26.8 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 1.1 |
2.1 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 1.1 |
2.1 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 1.1 |
24.5 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 1.1 |
2.1 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 1.1 |
16.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 1.1 |
1.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 1.1 |
1.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 1.0 |
1.0 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 1.0 |
1.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.0 |
6.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 1.0 |
4.1 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 1.0 |
3.0 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.0 |
9.0 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 1.0 |
3.0 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 1.0 |
3.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 1.0 |
5.0 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 1.0 |
3.0 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 1.0 |
3.0 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 1.0 |
7.9 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 1.0 |
1.0 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 1.0 |
1.0 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 1.0 |
2.9 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 1.0 |
10.8 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 1.0 |
2.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 1.0 |
4.9 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 1.0 |
3.9 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 1.0 |
10.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.0 |
7.7 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 1.0 |
7.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 1.0 |
3.8 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 1.0 |
6.7 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.0 |
2.9 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 1.0 |
5.7 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.9 |
10.4 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.9 |
6.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.9 |
3.8 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.9 |
0.9 |
GO:1902866 |
regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
| 0.9 |
3.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.9 |
2.8 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.9 |
3.7 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.9 |
4.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.9 |
2.7 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.9 |
4.6 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.9 |
3.6 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.9 |
5.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.9 |
0.9 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.9 |
12.6 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.9 |
1.8 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.9 |
2.7 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.9 |
8.9 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.9 |
2.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.9 |
2.7 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.9 |
2.7 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.9 |
24.8 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.9 |
32.7 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.9 |
3.5 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.9 |
3.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.9 |
0.9 |
GO:0071220 |
response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.9 |
5.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.9 |
15.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.9 |
0.9 |
GO:0014009 |
glial cell proliferation(GO:0014009) |
| 0.9 |
2.6 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.9 |
2.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.9 |
3.5 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.9 |
2.6 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.9 |
2.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.9 |
4.3 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.9 |
0.9 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.9 |
2.6 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.9 |
6.0 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.9 |
1.7 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.9 |
69.9 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.9 |
7.7 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.8 |
3.4 |
GO:1905050 |
positive regulation of metallopeptidase activity(GO:1905050) |
| 0.8 |
6.8 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.8 |
0.8 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.8 |
5.0 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.8 |
1.7 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.8 |
5.9 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.8 |
0.8 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.8 |
1.7 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.8 |
5.0 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.8 |
7.5 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.8 |
2.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.8 |
2.5 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.8 |
3.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.8 |
3.3 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.8 |
0.8 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.8 |
0.8 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.8 |
4.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.8 |
2.5 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.8 |
17.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.8 |
2.5 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.8 |
3.3 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.8 |
8.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.8 |
2.4 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.8 |
0.8 |
GO:0002200 |
somatic diversification of immune receptors(GO:0002200) |
| 0.8 |
3.3 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.8 |
6.5 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.8 |
4.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.8 |
1.6 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.8 |
4.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.8 |
0.8 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.8 |
7.2 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.8 |
4.8 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.8 |
4.8 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.8 |
4.0 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.8 |
6.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.8 |
8.6 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.8 |
3.9 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.8 |
5.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.8 |
5.5 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.8 |
3.9 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.8 |
1.6 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.8 |
2.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.8 |
8.6 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.8 |
2.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.8 |
1.5 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.8 |
2.3 |
GO:0042637 |
catagen(GO:0042637) |
| 0.8 |
3.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.8 |
2.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.8 |
0.8 |
GO:0042312 |
regulation of vasodilation(GO:0042312) |
| 0.8 |
5.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.8 |
6.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.8 |
3.8 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.8 |
9.1 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.8 |
0.8 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.8 |
8.3 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.8 |
3.0 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.7 |
1.5 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.7 |
1.5 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.7 |
5.2 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.7 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.7 |
5.9 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.7 |
16.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.7 |
8.0 |
GO:0070203 |
regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.7 |
8.7 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.7 |
8.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.7 |
3.6 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.7 |
2.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.7 |
4.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.7 |
4.3 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.7 |
2.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.7 |
17.3 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.7 |
1.4 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.7 |
10.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.7 |
0.7 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.7 |
3.6 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.7 |
5.0 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.7 |
1.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 |
7.0 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.7 |
2.8 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.7 |
6.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.7 |
33.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.7 |
40.0 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.7 |
2.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.7 |
7.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.7 |
2.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.7 |
2.1 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.7 |
1.4 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.7 |
6.1 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.7 |
3.4 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.7 |
1.4 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) |
| 0.7 |
1.4 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.7 |
1.4 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.7 |
4.1 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.7 |
5.4 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.7 |
2.7 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.7 |
0.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.7 |
2.0 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.7 |
13.8 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.7 |
0.7 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.7 |
12.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.7 |
1.3 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.6 |
3.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
1.3 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.6 |
0.6 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.6 |
3.9 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.6 |
15.5 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.6 |
1.9 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.6 |
3.2 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.6 |
3.9 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 0.6 |
1.9 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.6 |
10.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.6 |
1.9 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.6 |
2.6 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.6 |
1.3 |
GO:0032079 |
regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.6 |
5.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.6 |
1.9 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.6 |
0.6 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.6 |
192.2 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.6 |
3.1 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.6 |
1.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.6 |
1.9 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.6 |
1.2 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.6 |
8.6 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.6 |
1.2 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.6 |
2.4 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.6 |
0.6 |
GO:0032364 |
oxygen homeostasis(GO:0032364) regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.6 |
6.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.6 |
0.6 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.6 |
1.8 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.6 |
6.6 |
GO:0032691 |
negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.6 |
1.2 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.6 |
7.8 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.6 |
1.2 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.6 |
1.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.6 |
0.6 |
GO:0042483 |
negative regulation of odontogenesis(GO:0042483) |
| 0.6 |
5.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.6 |
1.8 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.6 |
1.2 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.6 |
1.2 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.6 |
3.0 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.6 |
3.0 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.6 |
1.8 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.6 |
2.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.6 |
2.4 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.6 |
3.5 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.6 |
1.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.6 |
2.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.6 |
12.1 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.6 |
22.5 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.6 |
1.7 |
GO:1902031 |
regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.6 |
1.1 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.6 |
1.1 |
GO:0061010 |
gall bladder development(GO:0061010) regulation of cardiac cell fate specification(GO:2000043) |
| 0.6 |
7.9 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.6 |
2.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.6 |
2.8 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.6 |
1.7 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.6 |
7.2 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.5 |
2.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.5 |
1.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.5 |
14.2 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.5 |
2.7 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.5 |
3.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.5 |
3.2 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.5 |
5.9 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.5 |
1.6 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.5 |
4.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.5 |
2.6 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.5 |
1.6 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.5 |
4.7 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.5 |
1.1 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.5 |
2.1 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.5 |
0.5 |
GO:0002739 |
regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.5 |
2.1 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.5 |
10.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.5 |
5.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.5 |
2.6 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.5 |
2.6 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.5 |
1.6 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.5 |
4.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.5 |
4.1 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.5 |
2.1 |
GO:0010712 |
regulation of collagen metabolic process(GO:0010712) positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.5 |
2.1 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.5 |
0.5 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.5 |
2.0 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.5 |
5.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.5 |
1.5 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.5 |
1.5 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.5 |
0.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 |
6.6 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.5 |
1.5 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.5 |
2.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.5 |
1.0 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 |
1.5 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.5 |
2.5 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.5 |
4.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.5 |
1.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 |
5.4 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.5 |
2.0 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.5 |
0.5 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.5 |
3.9 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.5 |
2.4 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.5 |
2.0 |
GO:0060021 |
palate development(GO:0060021) |
| 0.5 |
8.8 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.5 |
1.5 |
GO:0046016 |
positive regulation of transcription by glucose(GO:0046016) |
| 0.5 |
1.0 |
GO:0046386 |
deoxyribose phosphate catabolic process(GO:0046386) |
| 0.5 |
1.5 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.5 |
1.0 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.5 |
1.9 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.5 |
1.5 |
GO:0003340 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.5 |
1.5 |
GO:0046660 |
female sex differentiation(GO:0046660) |
| 0.5 |
1.0 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.5 |
1.4 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 |
0.5 |
GO:0071426 |
ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.5 |
11.0 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.5 |
1.0 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.5 |
1.4 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.5 |
0.5 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.5 |
2.4 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.5 |
2.4 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.5 |
1.4 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.5 |
2.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.5 |
0.9 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.5 |
2.8 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.5 |
4.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.5 |
1.4 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.5 |
5.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.5 |
26.7 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.4 |
8.4 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.4 |
3.5 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.4 |
2.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.4 |
2.2 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.4 |
0.4 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
0.9 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.4 |
0.4 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.4 |
3.5 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.4 |
1.3 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
2.6 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.4 |
0.9 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.4 |
7.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.4 |
2.1 |
GO:1901341 |
positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
1.3 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.4 |
0.4 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.4 |
1.7 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 |
0.9 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.4 |
0.4 |
GO:0002585 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.4 |
0.8 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.4 |
4.6 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.4 |
0.8 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.4 |
2.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.4 |
2.9 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.4 |
0.4 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.4 |
2.1 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.4 |
1.7 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.4 |
1.3 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.4 |
7.0 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.4 |
2.5 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.4 |
4.9 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 |
2.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.4 |
2.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.4 |
0.4 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.4 |
0.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.4 |
1.6 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.4 |
0.4 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.4 |
1.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.4 |
3.6 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.4 |
6.9 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.4 |
11.7 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.4 |
1.6 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.4 |
0.4 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.4 |
4.0 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.4 |
1.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.4 |
1.2 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.4 |
0.8 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.4 |
1.2 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.4 |
2.0 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.4 |
2.4 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.4 |
1.6 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.4 |
5.5 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.4 |
7.5 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.4 |
0.4 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.4 |
0.4 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.4 |
1.2 |
GO:0007320 |
insemination(GO:0007320) |
| 0.4 |
1.2 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.4 |
0.4 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.4 |
1.5 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.4 |
1.9 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.4 |
8.0 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.4 |
2.3 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.4 |
1.9 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.4 |
1.1 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.4 |
0.8 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
0.4 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.4 |
3.0 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.4 |
1.1 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.4 |
2.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.4 |
2.2 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.4 |
1.1 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.4 |
3.0 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.4 |
1.5 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.4 |
1.5 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.4 |
2.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.4 |
7.4 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.4 |
1.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 |
1.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.4 |
0.4 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.4 |
0.7 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.4 |
1.8 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.4 |
0.4 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.4 |
1.4 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.4 |
3.6 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.4 |
1.8 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.4 |
1.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.4 |
1.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.4 |
3.9 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.4 |
1.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.4 |
4.9 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.4 |
5.6 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.4 |
3.2 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.4 |
2.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.3 |
4.2 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.3 |
7.9 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.3 |
0.7 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.3 |
2.8 |
GO:0090132 |
epithelial cell migration(GO:0010631) tissue migration(GO:0090130) epithelium migration(GO:0090132) |
| 0.3 |
0.7 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
7.6 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.3 |
1.7 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.3 |
1.4 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 |
1.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.3 |
0.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.3 |
1.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.3 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
0.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
4.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.3 |
4.7 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.3 |
0.3 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.3 |
9.0 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.3 |
1.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
2.6 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.3 |
1.0 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
9.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.3 |
4.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.3 |
3.8 |
GO:1901343 |
negative regulation of vasculature development(GO:1901343) |
| 0.3 |
0.3 |
GO:0010896 |
negative regulation of sequestering of triglyceride(GO:0010891) regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 |
2.9 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 |
1.0 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.3 |
2.5 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.3 |
0.6 |
GO:0090114 |
cargo loading into COPII-coated vesicle(GO:0090110) COPII-coated vesicle budding(GO:0090114) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
4.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.3 |
0.9 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.3 |
0.9 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 |
10.6 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.3 |
0.3 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.3 |
1.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 |
0.3 |
GO:2000758 |
positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.3 |
1.5 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.3 |
0.6 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.3 |
0.9 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.3 |
0.3 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.3 |
4.3 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.3 |
4.0 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.3 |
0.6 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.3 |
1.5 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.3 |
0.9 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.3 |
2.1 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.3 |
0.9 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
0.6 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.3 |
1.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
1.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.3 |
0.3 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.3 |
4.4 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.3 |
0.3 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.3 |
0.6 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.3 |
0.9 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 |
0.3 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.3 |
2.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.3 |
0.6 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.3 |
0.3 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.3 |
8.4 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.3 |
4.1 |
GO:0035306 |
positive regulation of dephosphorylation(GO:0035306) |
| 0.3 |
0.9 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
1.7 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.3 |
3.7 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.3 |
5.7 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
0.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 |
1.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.3 |
6.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.3 |
1.7 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.3 |
1.1 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.3 |
1.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 |
1.1 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.3 |
0.3 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.3 |
1.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
0.3 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.3 |
1.4 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.3 |
2.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.3 |
3.3 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.3 |
1.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 |
1.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.3 |
1.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.3 |
0.3 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.3 |
4.9 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.3 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.3 |
4.3 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.3 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.3 |
0.5 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
9.7 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.3 |
11.5 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.3 |
2.7 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.3 |
10.3 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.3 |
1.1 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.3 |
0.5 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.3 |
1.8 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
1.8 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.3 |
1.8 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
0.3 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
1.3 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.3 |
2.6 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.3 |
2.8 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.3 |
9.4 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.3 |
3.6 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.3 |
1.8 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.3 |
0.8 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.3 |
38.1 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.3 |
3.0 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 |
1.0 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.3 |
3.0 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.2 |
0.5 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) |
| 0.2 |
0.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
0.5 |
GO:0009994 |
oocyte differentiation(GO:0009994) oocyte development(GO:0048599) |
| 0.2 |
3.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.2 |
2.4 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 |
1.0 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
1.0 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.2 |
0.7 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.2 |
0.2 |
GO:2001053 |
regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.2 |
1.9 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
1.0 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
1.9 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
2.9 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.2 |
1.4 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.2 |
4.3 |
GO:0048644 |
muscle organ morphogenesis(GO:0048644) |
| 0.2 |
0.7 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
0.2 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.2 |
2.6 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 |
2.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 |
1.2 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
0.7 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.2 |
10.7 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.2 |
0.9 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 |
1.4 |
GO:0046605 |
regulation of centrosome cycle(GO:0046605) |
| 0.2 |
0.2 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.2 |
1.2 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 0.2 |
6.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
0.7 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 |
4.8 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.2 |
0.9 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.2 |
3.2 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
2.9 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.2 |
0.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
9.0 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.2 |
0.4 |
GO:1901222 |
NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.2 |
0.4 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.2 |
0.4 |
GO:0009838 |
abscission(GO:0009838) |
| 0.2 |
0.7 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
3.3 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.2 |
0.9 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.2 |
2.6 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 |
1.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.2 |
2.4 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.2 |
3.9 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.2 |
0.8 |
GO:0071774 |
response to fibroblast growth factor(GO:0071774) |
| 0.2 |
0.6 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 |
1.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.2 |
0.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.4 |
GO:1901163 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
0.2 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.2 |
1.4 |
GO:2000060 |
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.2 |
1.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
0.6 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.2 |
0.8 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 |
14.8 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
0.4 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.8 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.2 |
2.0 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
0.8 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.2 |
0.8 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.2 |
0.4 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
3.2 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.2 |
4.6 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 |
0.9 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.2 |
1.5 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.2 |
0.8 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
4.9 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.2 |
0.8 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.2 |
2.3 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.2 |
5.4 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.2 |
3.0 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.2 |
0.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
0.6 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
0.9 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.2 |
1.4 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
0.9 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.8 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 |
2.0 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.2 |
1.4 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.2 |
3.0 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
0.5 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.2 |
0.3 |
GO:0032366 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.2 |
0.2 |
GO:1903311 |
regulation of mRNA metabolic process(GO:1903311) |
| 0.2 |
1.2 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.2 |
1.0 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.2 |
1.4 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.2 |
0.7 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
6.3 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.2 |
0.8 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
0.2 |
GO:0031023 |
microtubule organizing center organization(GO:0031023) |
| 0.2 |
2.7 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.2 |
1.9 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.2 |
0.2 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.2 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 |
0.2 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.2 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
1.5 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.2 |
18.3 |
GO:0044772 |
mitotic cell cycle phase transition(GO:0044772) |
| 0.2 |
0.8 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 |
0.7 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.2 |
40.4 |
GO:0006412 |
translation(GO:0006412) |
| 0.2 |
0.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
1.1 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.2 |
0.5 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.2 |
0.2 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.2 |
3.2 |
GO:0007588 |
excretion(GO:0007588) |
| 0.2 |
0.2 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.2 |
0.3 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.2 |
0.5 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
0.8 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.2 |
0.5 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
1.1 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 |
1.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.5 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 |
0.2 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.2 |
0.6 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
| 0.2 |
0.6 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.9 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
3.7 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.7 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
0.1 |
GO:0060405 |
regulation of penile erection(GO:0060405) |
| 0.1 |
0.6 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
1.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.6 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
| 0.1 |
0.7 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.1 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.1 |
0.1 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.1 |
1.3 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.1 |
0.6 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.1 |
0.4 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.1 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.4 |
GO:1903894 |
regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.1 |
0.1 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
0.3 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
2.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
2.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
1.5 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.3 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 |
0.5 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.1 |
2.9 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 |
2.7 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
0.8 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.4 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.1 |
4.0 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.1 |
1.8 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.1 |
0.3 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
3.1 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 |
0.9 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
4.6 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.1 |
0.6 |
GO:0045931 |
positive regulation of mitotic cell cycle(GO:0045931) |
| 0.1 |
1.5 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.1 |
0.9 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
1.7 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
3.6 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.1 |
0.7 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.1 |
0.2 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
1.8 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.7 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
4.7 |
GO:0071229 |
cellular response to acid chemical(GO:0071229) |
| 0.1 |
0.5 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
2.0 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.1 |
0.2 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.1 |
0.5 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
2.1 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.3 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 |
0.7 |
GO:0030098 |
lymphocyte differentiation(GO:0030098) |
| 0.1 |
0.8 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.1 |
GO:1905155 |
regulation of phagocytosis, engulfment(GO:0060099) positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
| 0.1 |
1.6 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
7.8 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.1 |
0.3 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.3 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
0.9 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
2.8 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.1 |
0.5 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.1 |
0.3 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.3 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
1.6 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.1 |
1.3 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.1 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
1.0 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
11.5 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.1 |
0.2 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.4 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.1 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.5 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.5 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
0.4 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.3 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.3 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.1 |
0.4 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.4 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.6 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
1.0 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.1 |
1.1 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.1 |
0.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.9 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
1.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.3 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.5 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.6 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
0.1 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.6 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 |
0.5 |
GO:0046189 |
phenol-containing compound biosynthetic process(GO:0046189) |
| 0.1 |
0.2 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.1 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.5 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
1.2 |
GO:0009952 |
anterior/posterior pattern specification(GO:0009952) |
| 0.1 |
0.1 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.1 |
1.1 |
GO:0022618 |
ribonucleoprotein complex assembly(GO:0022618) |
| 0.1 |
0.4 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.1 |
2.0 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.1 |
GO:0050665 |
hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.1 |
1.4 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
0.3 |
GO:0019395 |
fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
| 0.1 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.3 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.5 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.3 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.1 |
0.2 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
| 0.1 |
1.8 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.1 |
0.5 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.1 |
0.5 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.1 |
0.4 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.1 |
0.7 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 |
0.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
1.3 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.6 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
2.1 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.1 |
0.8 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.2 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.5 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
1.0 |
GO:0042476 |
odontogenesis(GO:0042476) |
| 0.1 |
1.0 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.7 |
GO:0061647 |
histone H3-K9 modification(GO:0061647) |
| 0.0 |
1.0 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 |
0.2 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.2 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.4 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.1 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.0 |
0.2 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.0 |
0.4 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.4 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
1.2 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.1 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.0 |
0.1 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.1 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.0 |
0.6 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.1 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.8 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.0 |
0.1 |
GO:0070723 |
response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
| 0.0 |
0.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.3 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 |
0.2 |
GO:0061180 |
mammary gland epithelium development(GO:0061180) |
| 0.0 |
0.5 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0045622 |
regulation of T-helper cell differentiation(GO:0045622) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.0 |
GO:1903337 |
positive regulation of vacuolar transport(GO:1903337) |
| 0.0 |
0.0 |
GO:0032735 |
positive regulation of interleukin-12 production(GO:0032735) |
| 0.0 |
0.3 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.6 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.4 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.0 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
| 0.0 |
0.5 |
GO:0060348 |
bone development(GO:0060348) |
| 0.0 |
0.0 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 |
1.2 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.0 |
0.1 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.0 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 |
0.1 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.1 |
GO:0019755 |
carbon dioxide transport(GO:0015670) one-carbon compound transport(GO:0019755) |
| 0.0 |
0.0 |
GO:0060947 |
cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.0 |
0.0 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.2 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.0 |
0.0 |
GO:0019731 |
antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
| 0.0 |
0.1 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.1 |
GO:0014911 |
positive regulation of smooth muscle cell migration(GO:0014911) |
